Literature DB >> 7325985

Collagen cross-linking compounds in human urine.

Z Gunja-Smith, R J Boucek.   

Abstract

We report the isolation and chemical characterization of collagen cross-linking compounds, 3-hydroxypyridinium and dihydroxylysinonorleucine, from human urine.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7325985      PMCID： PMC1163193          DOI： 10.1042/bj1970759

Source DB:  PubMed          Journal:  Biochem J        ISSN： 0264-6021            Impact factor:   3.857


  8 in total

1.  Effect of vitamin D on the content of the stable crosslink, pyridinoline, in chick bone collagen.

Authors:  D Fujimoto; M Fujie; E Abe; T Suda
Journal:  Biochem Biophys Res Commun       Date:  1979-11-14       Impact factor: 3.575

2.  Isolation and characterization of a fluorescent material in bovine achilles tendon collagen.

Authors:  D Fujimoto
Journal:  Biochem Biophys Res Commun       Date:  1977-06-20       Impact factor: 3.575

3.  Relative stabilities of the intermediate reducible crosslinks present in collagen fibres.

Authors:  S P Robins; A J Bailey
Journal:  FEBS Lett       Date:  1973-07-01       Impact factor: 4.124

4.  The hydroxypyridinium crosslinks of skeletal collagens: their measurement, properties and a proposed pathway of formation.

Authors:  D R Eyre; H Oguchi
Journal:  Biochem Biophys Res Commun       Date:  1980-01-29       Impact factor: 3.575

5.  The chemistry of the collagen cross-links. The mechanism of stabilization of the reducible intermediate cross-links.

Authors:  S P Robins; A J Bailey
Journal:  Biochem J       Date:  1975-08       Impact factor: 3.857

6.  Pyridinoline, a non-reducible crosslink of collagen. Quantitative determination, distribution, and isolation of a crosslinked peptide.

Authors:  D Fujimoto; T Moriguchi
Journal:  J Biochem       Date:  1978-03       Impact factor: 3.387

7.  A possible role for dehydrodihydroxylysinonorleucine in collagen fibre and bundle formation.

Authors:  R J Boucek; N L Noble; Z Gunja-Smith
Journal:  Biochem J       Date:  1979-03-01       Impact factor: 3.857

8.  Desmosines in human urine. Amounts in early development and in Marfan's syndrome.

Authors:  Z Gunja-Smith; R J Boucek
Journal:  Biochem J       Date:  1981-03-01       Impact factor: 3.857
  8 in total
  13 in total

1.  Biochemical markers of bone turnover: part I: biochemistry and variability.

Authors:  Markus J Seibel
Journal:  Clin Biochem Rev       Date:  2005-11

2.  New biochemical markers of bone resorption derived from collagen breakdown in the study of postmenopausal osteoporosis.

Authors:  R Guerrero; M A Diaz Martin; E M Diaz Diego; T Disla; A Rapado; C de la Piedra
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

3.  An enzyme-linked immunoassay for the collagen cross-link pyridinoline.

Authors:  S P Robins
Journal:  Biochem J       Date:  1982-12-01       Impact factor: 3.857

Review 4.  Recent advances in the use of serological bone formation markers to monitor callus development and fracture healing.

Authors:  Marlon O Coulibaly; Debra L Sietsema; Travis A Burgers; Jim Mason; Bart O Williams; Clifford B Jones
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2010       Impact factor: 1.807

5.  Urinary excretion of pyridinium crosslinks of collagen in patients with osteoporosis and the effects of bone fracture.

Authors:  A M McLaren; L D Hordon; H A Bird; S P Robins
Journal:  Ann Rheum Dis       Date:  1992-05       Impact factor: 19.103

6.  Prevention of bone resorption by intake of phytoestrogens in postmenopausal women: a meta-analysis.

Authors:  Pooneh Salari Sharif; Shekoufeh Nikfar; Mohammad Abdollahi
Journal:  Age (Dordr)       Date:  2010-09-09

7.  Urinary and synovial pyridinium crosslink concentrations in patients with rheumatoid arthritis and osteoarthritis.

Authors:  L Sinigaglia; M Varenna; L Binelli; F Bartucci; M Arrigoni; R Ferrara; G Abbiati
Journal:  Ann Rheum Dis       Date:  1995-02       Impact factor: 19.103

Review 8.  Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use.

Authors:  S Patel; A R Lyons; D J Hosking
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

9.  Measurement of the cross linking compound, pyridinoline, in urine as an index of collagen degradation in joint disease.

Authors:  S P Robins; P Stewart; C Astbury; H A Bird
Journal:  Ann Rheum Dis       Date:  1986-12       Impact factor: 19.103

10.  Urinary biochemical markers for bone resorption during the menstrual cycle.

Authors:  I Gorai; O Chaki; M Nakayama; H Minaguchi
Journal:  Calcif Tissue Int       Date:  1995-08       Impact factor: 4.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.